MedTrace Logo

Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model

NCT07017972 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2025-08-07

No results posted yet for this study

Summary

This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software.

In addition, the professional user simulated use will ensure correct and easy use of the AI applications.

Conditions

  • Fertility Disorders

Interventions

DEVICE

AI evaluation of embryos

AI evaluation of embryos inside a time-lapse incubator.

Sponsors & Collaborators

  • Fairtility

    lead INDUSTRY

Principal Investigators

  • Klaus Wiemer, PhD · Fairtility

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-20
Primary Completion
2027-06-20
Completion
2027-06-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07017972 on ClinicalTrials.gov